Platinum-Sensitive Ovarian Cancer
13 clinical trials · Condition
◉ Watch Platinum-Sensitive Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors (NCT05002868) | Rhizen Pharmaceuticals SA | 2021-10-05 |
| Variance of HRD From Paired Ovarian Cancer (NCT05069818) | Xiaoxiang Chen | 2021-10-01 |
| OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC (NCT04713514) | ARCAGY/ GINECO GROUP | 2021-08-05 |
| Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer (NCT04457089) | Marc Goodman | 2021-01-25 |
| Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer (NCT02978222) | Marker Therapeutics, Inc. | 2017-07-20 |
| Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment (NCT02035345) | Massachusetts General Hospital | 2014-01-01 |
| A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer (NCT01847274) | Tesaro, Inc. | 2013-06-21 |
Track Platinum-Sensitive Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.